A Randomized, Observer Blinded, Comparative, Phase I Safety Study in Two Age De-escalating Cohorts to Assess the Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Typhoid vaccine Vi DT conjugate International Vaccine Institute/Incepta/SK Bioscience/PT Biofarma (Primary) ; Influenza virus vaccine; Pneumococcal vaccine conjugate; Typhoid vaccine Vi-polysaccharide
- Indications Typhoid
- Focus Adverse reactions
- Sponsors PT Bio Farma
- 04 Mar 2018 Status changed from active, no longer recruiting to completed.
- 01 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 12 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Sep 2017.